F. J. Bemelman

538 total citations
22 papers, 327 citations indexed

About

F. J. Bemelman is a scholar working on Immunology, Epidemiology and Surgery. According to data from OpenAlex, F. J. Bemelman has authored 22 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in F. J. Bemelman's work include Pregnancy and Medication Impact (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). F. J. Bemelman is often cited by papers focused on Pregnancy and Medication Impact (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). F. J. Bemelman collaborates with scholars based in Netherlands, France and United States. F. J. Bemelman's co-authors include Ineke J. M. ten Berge, Marije C. Baas, Caroline E. Visser, Shaikh A. Nurmohamed, Hazra S. Moeniralam, Paul P. Tak, Marieke E. Doorenspleet, Ester B. M. Remmerswaal, Frank Baas and Niek de Vries and has published in prestigious journals such as Blood, PLoS Pathogens and Transplantation.

In The Last Decade

F. J. Bemelman

22 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. J. Bemelman Netherlands 10 130 120 57 46 40 22 327
Grażyna Moszkowska Poland 10 177 1.4× 103 0.9× 66 1.2× 103 2.2× 81 2.0× 38 385
Elizabeth Wallin United Kingdom 8 166 1.3× 44 0.4× 63 1.1× 47 1.0× 21 0.5× 13 355
Dongyuan Xia United States 9 206 1.6× 101 0.8× 112 2.0× 62 1.3× 17 0.4× 13 411
Rubin Rh United States 10 80 0.6× 109 0.9× 43 0.8× 49 1.1× 31 0.8× 24 314
Sridhar R. Allam United States 8 121 0.9× 58 0.5× 76 1.3× 122 2.7× 42 1.1× 18 277
Touraine Jl France 11 94 0.7× 86 0.7× 110 1.9× 70 1.5× 20 0.5× 81 395
Julien Vionnet Switzerland 11 48 0.4× 80 0.7× 127 2.2× 96 2.1× 31 0.8× 35 313
K. Nachbaur Austria 8 63 0.5× 297 2.5× 68 1.2× 19 0.4× 18 0.5× 12 471
Lisa Anderson United States 9 63 0.5× 72 0.6× 37 0.6× 26 0.6× 92 2.3× 16 335
Charlotte Colosio France 9 33 0.3× 60 0.5× 49 0.9× 108 2.3× 42 1.1× 18 254

Countries citing papers authored by F. J. Bemelman

Since Specialization
Citations

This map shows the geographic impact of F. J. Bemelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. J. Bemelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. J. Bemelman more than expected).

Fields of papers citing papers by F. J. Bemelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. J. Bemelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. J. Bemelman. The network helps show where F. J. Bemelman may publish in the future.

Co-authorship network of co-authors of F. J. Bemelman

This figure shows the co-authorship network connecting the top 25 collaborators of F. J. Bemelman. A scholar is included among the top collaborators of F. J. Bemelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. J. Bemelman. F. J. Bemelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duineveld, Caroline, Kioa L. Wijnsma, F. J. Bemelman, et al.. (2023). Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation. Kidney International Reports. 8(4). 715–726. 9 indexed citations
2.
Heijden, Olivier W.H. van der, A. Titia Lely, Margriet F. C. de Jong, et al.. (2021). Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study. Transplant International. 34(12). 2669–2679. 7 indexed citations
3.
Schlingemann, Reinier O., et al.. (2017). Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. International Ophthalmology. 38(1). 399–407. 18 indexed citations
4.
Heutinck, Kirstin M., Sandro L. Yong, Lennart Tonneijck, et al.. (2015). Virus-Specific CD8+ T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV. American Journal of Transplantation. 16(5). 1480–1491. 34 indexed citations
5.
Minnee, Robert C., et al.. (2014). Fast Track Hand-Assisted Laparoscopic Donor Nephrectomy: A Randomized Clinical Trial.. Transplantation. 98. 607–607. 3 indexed citations
6.
Bemelman, F. J., et al.. (2013). Chylous ascites after laparoscopic hand-assisted donor nephrectomy: Is it specific for the left-side?. Urology Annals. 5(1). 45–45. 18 indexed citations
7.
Klarenbeek, Paul L., Ester B. M. Remmerswaal, Ineke J. M. ten Berge, et al.. (2012). Deep Sequencing of Antiviral T-Cell Responses to HCMV and EBV in Humans Reveals a Stable Repertoire That Is Maintained for Many Years. PLoS Pathogens. 8(9). e1002889–e1002889. 85 indexed citations
8.
Rombach, Saskia M., Marije C. Baas, Ineke J. M. ten Berge, et al.. (2010). The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease. Nephrology Dialysis Transplantation. 25(8). 2549–2556. 32 indexed citations
9.
Baas, Marije C., Victor E. A. Gerdes, Joost C.M. Meijers, Ineke J. M. ten Berge, & F. J. Bemelman. (2010). INCREASED THROMBOGENICITY ASSOCIATED WITH MTOR INHIBITITION. Transplantation. 90. 439–439. 1 indexed citations
10.
Baas, Marije C., et al.. (2009). Mumps: Not an Innocent Bystander in Solid Organ Transplantation. American Journal of Transplantation. 9(9). 2186–2189. 20 indexed citations
11.
Aalten, Jeroen, F. J. Bemelman, E.M. Van Den Berg‐Loonen, et al.. (2009). Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Nephrology Dialysis Transplantation. 24(8). 2559–2566. 21 indexed citations
12.
Berge, Ineke J. M. ten, et al.. (2008). MINIMIZATION OF IMMUNOSUPPRESSIVE DRUG THERAPY AT 6 MONTHS AFTER RENAL TRANSPLANTATION: EVEROLIMUS OR CYCLOSPORIN SUPERIOR TO MYCOPHENOLATE SODIUM. Transplantation. 86(2S). 186–186. 2 indexed citations
13.
Nurmohamed, Shaikh A., et al.. (2007). Hyperammonemia in Generalized Mycobacterium genavense Infection after Renal Transplantation. American Journal of Transplantation. 7(3). 722–723. 34 indexed citations
14.
Bemelman, F. J., et al.. (2002). No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients. Transplantation Proceedings. 34(8). 3165–3167. 1 indexed citations
15.
16.
Bemelman, F. J., et al.. (1995). Biphasic granulocytopenia after administration of the first dose of OKT3.. PubMed. 126(6). 571–9. 4 indexed citations
17.
Bemelman, F. J., et al.. (1994). Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependent. Transplant Immunology. 2(1). 47–51. 4 indexed citations
18.
Bemelman, F. J., et al.. (1994). Increased levels of sTNF receptors following OKT3 treatment.. PubMed. 26(6). 3094–5. 1 indexed citations
19.
Bemelman, F. J., et al.. (1994). Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3. Nephrology Dialysis Transplantation. 9(12). 1786–1790. 5 indexed citations
20.
Verhoeff, N. P. L. G., F. J. Bemelman, W M Wiersinga, & Eric A. van Royen. (1993). Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma. European Journal of Nuclear Medicine and Molecular Imaging. 20(6). 555–561. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grażyna Moszkowska Breakdown of academic impact, for papers by Elizabeth Wallin Breakdown of academic impact, for papers by Dongyuan Xia Breakdown of academic impact, for papers by Rubin Rh Breakdown of academic impact, for papers by Sridhar R. Allam Breakdown of academic impact, for papers by Touraine Jl Breakdown of academic impact, for papers by Julien Vionnet Breakdown of academic impact, for papers by K. Nachbaur Breakdown of academic impact, for papers by Lisa Anderson Breakdown of academic impact, for papers by Charlotte Colosio
Rankless by CCL
2026